Core Viewpoint - Arcturus Therapeutics (ARCT) has seen a 7.5% increase in share price over the past four weeks, closing at $12.81, with analysts suggesting a potential upside of 371.4% based on a mean price target of $60.38 [1][12]. Price Targets and Analyst Estimates - The mean price target is derived from eight short-term estimates, with a standard deviation of $33.97, indicating variability among analysts [2]. - The lowest price target of $32 suggests a 149.8% increase, while the highest target of $140 indicates a potential surge of 992.9% [2]. - A low standard deviation among price targets suggests a strong consensus among analysts regarding the stock's price direction [9]. Earnings Estimates and Analyst Agreement - Analysts show strong agreement in revising earnings estimates upward, which is a positive indicator for potential stock upside [4][11]. - The Zacks Consensus Estimate for the current year has increased by 42.1% over the past month, with four estimates rising and no negative revisions [12]. - ARCT holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors [13]. Caution on Price Targets - While price targets are a common metric for investors, relying solely on them can be misleading, as they often do not accurately predict stock price movements [3][7][10]. - Analysts may set overly optimistic price targets due to business incentives, which can inflate expectations [8].

Shares of Semtech (SMTC) have gained 9.4% over the past four weeks to close the last trading session at $37.33, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $56.33 indicates a potential upside of 50.9%.The average comprises 12 short-term price targets ranging from a low of $43 to a high of $68, with a standard deviation of $8.32. While the lowest estimate indicates an increas ...

Core Viewpoint - Backblaze, Inc. (BLZE) shows significant potential for upside, with a mean price target of $10.83 indicating a 90% upside from the current price of $5.70 [1] Price Targets - The average price target consists of six estimates ranging from a low of $8 to a high of $14, with a standard deviation of $1.94, suggesting a variability in analyst estimates [2] - The lowest estimate indicates a potential increase of 40.4%, while the highest suggests a 145.6% upside [2] Analyst Sentiment - Analysts exhibit strong agreement regarding BLZE's ability to report better earnings than previously predicted, which supports the view of potential upside [4] - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 4%, with four estimates moving higher and no negative revisions [12] Zacks Rank - BLZE holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - This rank, along with a strong externally-audited track record, serves as a conclusive indicator of the stock's potential upside in the near term [13] Caution on Price Targets - While price targets are a common metric for investors, relying solely on them may not be wise due to the questionable ability and unbiasedness of analysts in setting these targets [3][7] - Analysts often set overly optimistic price targets influenced by business relationships, which can lead to inflated estimates [8]

Pan American Silver (PAAS) closed the last trading session at $24.20, gaining 0.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $31.23 indicates a 29.1% upside potential.The mean estimate comprises nine short-term price targets with a standard deviation of $4.44. While the lowest estimate of $26 indicates a 7.4% increase from the current price level, the most optimistic analyst ...

Eastern Bankshares, Inc. (EBC) closed the last trading session at $14.78, gaining 0.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $19.25 indicates a 30.2% upside potential.The average comprises four short-term price targets ranging from a low of $16 to a high of $23, with a standard deviation of $2.99. While the lowest estimate indicates an increase of 8.3% from the current pr ...

Core Viewpoint - Barrick Gold (B) shows potential for significant upside, with a mean price target of $24.39 indicating a 27.9% increase from the current price of $19.07 [1] Price Targets - The average of 16 short-term price targets ranges from a low of $21 to a high of $30.96, with a standard deviation of $2.90, suggesting a variability in estimates [2] - The lowest estimate indicates a 10.1% increase, while the highest suggests a 62.4% upside [2] Analyst Sentiment - Analysts are optimistic about Barrick Gold's earnings prospects, as indicated by a positive trend in earnings estimate revisions, which correlates with potential stock price movements [4][11] - The Zacks Consensus Estimate for the current year has increased by 2.2% over the past month, with three estimates revised higher and no negative revisions [12] Zacks Rank - Barrick Gold holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13]

Group 1 - The core viewpoint is that Benitec Biopharma Limited (BNTC) has significant upside potential, with a mean price target of $25.71 indicating an 83.9% increase from its current price of $13.98 [1] - The mean estimate consists of seven short-term price targets with a standard deviation of $6.70, suggesting variability in analyst predictions; the lowest estimate is $17 (21.6% increase), while the highest is $35 (150.4% increase) [2] - Analysts show strong agreement on BNTC's ability to report better earnings than previously predicted, which supports the expectation of stock upside [4][11] Group 2 - The Zacks Consensus Estimate for BNTC has increased by 15.6% due to three upward revisions in earnings estimates over the last 30 days, with no negative revisions [12] - BNTC holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for near-term upside [13] - While price targets may not be entirely reliable, the direction they imply appears to be a good guide for potential price movement [13]

Oportun Financial Corporation (OPRT) closed the last trading session at $6.90, gaining 57.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $9.04 indicates a 31% upside potential.The mean estimate comprises seven short-term price targets with a standard deviation of $1.70. While the lowest estimate of $6.50 indicates a 5.8% decline from the current price level, the most optimistic ...

Core Viewpoint - Backblaze, Inc. (BLZE) shares have increased by 13.4% in the past four weeks, closing at $5.32, with a potential upside indicated by Wall Street analysts' price targets suggesting a mean estimate of $10.83, representing a 103.6% upside [1] Price Targets - The average price targets from analysts range from a low of $8 to a high of $14, with a standard deviation of $1.94, indicating variability in estimates; the lowest estimate suggests a 50.4% increase, while the highest points to a 163.2% upside [2] - A low standard deviation among price targets suggests a high degree of agreement among analysts regarding the stock's price movement direction [9] Earnings Estimates - Analysts have shown increasing optimism about BLZE's earnings prospects, with a strong consensus in revising EPS estimates higher, which correlates with potential stock price increases [11] - The Zacks Consensus Estimate for the current year has risen by 3.3% over the past month, with four estimates increasing and no negative revisions [12] Zacks Rank - BLZE holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating a strong potential upside in the near term [13]

Inspired Entertainment (INSE) closed the last trading session at $8.17, gaining 12.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $12.40 indicates a 51.8% upside potential.The average comprises five short-term price targets ranging from a low of $10 to a high of $16, with a standard deviation of $2.30. While the lowest estimate indicates an increase of 22.4% from the current pr ...